Pharmaceutical News

Kainova Therapeutics Begins European Patient Enrollment in Groundbreaking Cancer Immunotherapy Trial

/ April 14, 2026

Kainova Therapeutics has started enrolling patients in Europe for an important early-stage clinical trial called the DOMISOL study. This trial […]

/ April 13, 2026

The United States Pharmacopeia (USP), a nonprofit organization that sets quality standards for medicines, has issued a new report highlighting

/ April 12, 2026

This week, several important updates in the pharmaceutical industry could affect how medicines and vaccines are developed, distributed, and supplied

/ April 11, 2026

Oxford BioTherapeutics (OBT) has started a long-term partnership with Bristol Myers Squibb (BMS) to create and develop new cancer therapies

/ April 10, 2026

Artificial Intelligence (AI) is being talked about as the future of drug development, with promises of faster, smarter, and more

/ April 8, 2026

A recent study has found that combining an antidepressant with a small molecule drug called Caplyta (lumateperone) can significantly improve

/ April 7, 2026

BioNTech, the German biotech company known for its COVID-19 vaccine, has announced plans to close its Singapore manufacturing plant and

/ April 6, 2026

A second weight-loss pill, called Foundayo (orforglipron), has just been approved in the U.S. by the FDA. This new medication

/ April 5, 2026

A new medication called elegrobart, developed by Viridian Therapeutics, has shown encouraging results in a large clinical trial for people

/ April 4, 2026

Pharmaceutical companies now have more ways than ever to communicate with doctors and other healthcare providers (HCPs). These include traditional